Total Valuation
Park Ha Biological Technology has a market cap or net worth of $2.33M. The enterprise value is -$2.79M.
Market Cap$2.33M
Enterprise Value-$2.79M
Share Statistics
Park Ha Biological Technology has 5,983,216 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,983,216
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Park Ha Biological Technology’s return on equity (ROE) is -6.10 and return on invested capital (ROIC) is -578.41%.
Return on Equity (ROE)-6.10
Return on Assets (ROA)-4.09
Return on Invested Capital (ROIC)-578.41%
Return on Capital Employed (ROCE)-5.93
Revenue Per Employee61.58K
Profits Per Employee-594.26K
Employee Count41
Asset Turnover0.42
Inventory Turnover1.68
Valuation Ratios
The current PE Ratio of Park Ha Biological Technology is ―. Park Ha Biological Technology’s PEG ratio is 0.00010.
PE Ratio―
PS Ratio4.37
PB Ratio2.76
Price to Fair Value2.76
Price to FCF-3.71K
Price to Operating Cash Flow-3.97
PEG Ratio0.00010
Income Statement
In the last 12 months, Park Ha Biological Technology had revenue of 2.52M and earned -24.36M in profits. Earnings per share was -41.38.
Revenue2.52M
Gross Profit2.38M
Operating Income-24.15M
Pretax Income-24.08M
Net Income-24.36M
EBITDA-23.97M
Earnings Per Share (EPS)-41.38
Cash Flow
In the last 12 months, operating cash flow was -409.96K and capital expenditures -467.51K, giving a free cash flow of -877.47K billion.
Operating Cash Flow-409.96K
Free Cash Flow-877.47K
Free Cash Flow per Share-0.15
Dividends & Yields
Park Ha Biological Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change-99.09%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)8.22M
Important Dates
Park Ha Biological Technology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Park Ha Biological Technology as a current ratio of 2.92, with Debt / Equity ratio of 3.46%
Current Ratio2.92
Quick Ratio2.88
Debt to Market Cap<0.01
Net Debt to EBITDA0.15
Interest Coverage Ratio-589.00K
Taxes
In the past 12 months, Park Ha Biological Technology has paid 280.65K in taxes.
Income Tax280.65K
Effective Tax Rate-0.01
Enterprise Valuation
Park Ha Biological Technology EV to EBITDA ratio is -0.31, with an EV/FCF ratio of -2.50K.
EV to Sales2.94
EV to EBITDA-0.31
EV to Free Cash Flow-2.50K
EV to Operating Cash Flow86.45
Balance Sheet
Park Ha Biological Technology has $5.66M in cash and marketable securities with $186.33K in debt, giving a net cash position of $5.47M billion.
Cash & Marketable Securities$5.66M
Total Debt$186.33K
Net Cash$5.47M
Net Cash Per Share$0.91
Tangible Book Value Per Share$6.77
Margins
Gross margin is 89.94%, with operating margin of -956.45%, and net profit margin of -965.00%.
Gross Margin89.94%
Operating Margin-956.45%
Pretax Margin-953.89%
Net Profit Margin-965.00%
EBITDA Margin-949.55%
EBIT Margin-953.88%
Analyst Forecast
The average price target for Park Ha Biological Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-8.12%
EPS Growth Forecast76.39%